Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Naturally arising CD25(+)CD4(+) regulatory T cells actively maintain immunological self-tolerance. Deficiency in or dysfunction of these cells can be a cause of autoimmune disease. A reduction in their number or function can also elicit tumor immunity, whereas their antigen-specific population expansion can establish transplantation tolerance. They are therefore a good target for designing ways to induce or abrogate immunological tolerance to self and non-self antigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growing evidence has shown that Treg cells are recruited into the TME and behave as powerful immunosuppressors.61, 62”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [62]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Self-citationFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“In addition, they specifically express Foxp3 , which encodes a transcription factor, as a key control gene in their development and functio”
BackgroundPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Self-citationA CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Self-citationThe Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“The fact that many tumor-associated antigens recognized by autologous T cells in cancer patients are antigenically normal self constituents indicates that natural CD25 + CD4 + T reg cells engaged in the maintenance of self-tolerance may concomitantly impede immunosurveillance against autologous tumor cell”
BackgroundTivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Research works printed but not linked: 1
- Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. A crucial role of IL-2 in the homeostatic maintenance of CD25+CD4+ regulatory T cells: induction of autoimmune disease by neutralization of IL-2. J. Exp. Med. (in the press).
Cited by
Items 401–500 of 1,010
Giannopoulos, K., Kaminska, W., Hus, I., & Dmoszynska, A. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.575 · Cited by 124
“Dendritic cells (DCs) (Banchereau et al, 2000) and T regulatory cells (Tregs) (Sakaguchi, 2005) are the most important cells in the immune system, able to control peripheral tolerance as well as response to foreign and tumour antigens.”
BackgroundSato, S. (2006) · International Immunology · doi:10.1093/intimm/dxl082 · Cited by 121
Li, W., Kim, M.-G., Gourley, T. S., McCarthy, B. P., Sant’Angelo, D. B., & Chang, C. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.002 · Cited by 130
Zaiss, M. M., Sarter, K., Hess, A., Engelke, K., Böhm, C., Nimmerjahn, F., Voll, R., Schett, G., & David, J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27535 · Cited by 122
In vivo imaging of T cell delivery to tumors after adoptive transfer therapy
Pittet, M. J., Grimm, J., Berger, C. R., Tamura, T., Wojtkiewicz, G., Nahrendorf, M., Romero, P., Swirski, F. K., & Weissleder, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704460104 · Cited by 121
Regulatory T-Cell Immunity in Atherosclerosis
Mallat, Z., Ait‐Oufella, H., & Tedgui, A. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.03.001 · Cited by 133
Srivastava, P. K. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.01.009 · Cited by 123
Tolerance strategies for stem-cell-based therapies
Chidgey, A. P., Layton, D., Trounson, A. O., & Boyd, R. L. (2008) · Nature · doi:10.1038/nature07041 · Cited by 135
“A lack of T reg cells or the presence of defective T reg cells is strongly associated with the development of autoimmunit”
BackgroundMaking sense of regulatory T cell suppressive function
Shalev, I., Schmelzle, M., Robson, S. C., & Levy, G. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.04.003 · Cited by 121
“Furthermore, treatment of naive normal mice with neutralizing antibody to circulating IL-2 causes decreases in Treg cell numbers and provokes autoimmunity [65].”
BackgroundThe impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer
Khazaie, K., & von Boehmer, H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.11.006 · Cited by 131
Induced Regulatory T Cells Promote Tolerance When Stabilized by Rapamycin and IL-2 In Vivo
Zhang, P., Tey, S., Koyama, M., Kuns, R., Olver, S., Lineburg, K., Lor, M., Teal, B. E., Raffelt, N. C., Raju, J., et al. (2013) · Journal of Immunology · doi:10.4049/jimmunol.1301181 · Cited by 110
The role of regulatory T-cells in glioma immunology
Ooi, Y. C., Tran, P., Ung, N. M., Thill, K., Trang, A., Fong, B., Nagasawa, D. T., Lim, M. K., & Yang, I. (2014) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.12.004 · Cited by 128
“[44] Sakaguchi S.”
BackgroundAre regulatory T-cells linked with aging?
Dejaco, C., Duftner, C., & Schirmer, M. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.01.008 · Cited by 133
Epithelia: lymphocyte interactions in the gut
Dahan, S., Roth‐Walter, F., Arnaboldi, P. M., Agarwal, S., & Mayer, L. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00484.x · Cited by 133
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management
Oo, Y. H., Hübscher, S. G., & Adams, D. (2010) · Hepatology International · doi:10.1007/s12072-010-9183-5 · Cited by 130
Re-Examining the Role of TNF in MS Pathogenesis and Therapy
Fresegna, D., Bullitta, S., Musella, A., Rizzo, F. R., Vito, F. D., Guadalupi, L., Caioli, S., Balletta, S., Sanna, K., Dolcetti, E., et al. (2020) · Cells · doi:10.3390/cells9102290 · Cited by 136
“By contrast, TNFR1 is barely detectable in these cells [53,54].”
BackgroundTalaat, R. M., El-Maghraby, A. M., Barakat, S. S. E. D., & El-Shahat, M. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12279 · Cited by 119
Liu, Y.-W., Su, Y., Ong, W.-K., Cheng, T.-H., & Tsai, Y.-C. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.09.013 · Cited by 125
Swee, L. K., Bosco, N., MALISSEN, B., Ceredig, R., & Rolink, A. G. (2009) · Blood · doi:10.1182/blood-2008-06-161026 · Cited by 126
In vitro effects of cyclosporine a and tacrolimus on regulatory T-cell proliferation and function
Miroux, C., Morales, O., Ghazal, K., Othman, S. B., de Launoit, Y., Pancré, V., Conti, F., & Delhem, N. (2012) · Transplantation · doi:10.1097/tp.0b013e3182590d8f · Cited by 117
“Tregs account for 5% to 10% of peripheral CD4 T cells; they constitutively express CD25 (3), can suppress host immune responses in the context of autoimmune diseases and transplantation (4, 5), and have been shown to be an essential component in immune tolerance (6).”
BackgroundHmida, N. B., Ahmed, M. B., Moussa, A., Rejeb, M. B., Saïd, Y., Kourda, N., Meresse, B., Abdeladhim, M., Louzir, H., & Cerf–Bensussan, N. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.397 · Cited by 117
“One important mechanism to achieve and maintain tolerance to diet ary proteins relies on the generation and activation of CD4+CD25+FOXP3+ T regulatory cells (T regs), a subset of lymphocytes initially identified by Sakaguchi in mice for their role against autoimmunity (reviewed in (3)).”
BackgroundHormonal modulation of the immune system — A spotlight on the role of progestogens
Tan, I. J., Peeva, E., & Zandman‐Goddard, G. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.02.004 · Cited by 140
Cytokine regulation networks in the cancer microenvironment
Sheu, B., Chang, W.-C., Cheng, C.-Y., Lin, H., Chang, D.-Y., & Huang, S.-C. (2008) · Frontiers in bioscience · doi:10.2741/3152 · Cited by 117
“Treg cells are thought to regulate peripheral tolerance to self-Ags and have also been shown to suppress anti-tumor immunity (122).”
BackgroundLee, H.-Y., Hong, Y.-K., Yun, H.-J., Kim, Y.-M., Kim, J.-R., & Yoo, W.-H. (2008) · Rheumatology · doi:10.1093/rheumatology/ken108 · Cited by 115
Miyagaki, T., Fujimoto, M., & Sato, S. (2015) · International Immunology · doi:10.1093/intimm/dxv026 · Cited by 116
The Immune System: Role in Hypertension
Schiffrin, E. L. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.009 · Cited by 121
“CD4 T lymphocytes become Treg under the influence of transcription factor X-linked forkhead/winged helix (Foxp3).(15) As mentioned, some Treg may express CD8 rather than CD4.”
BackgroundGlucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy
Engler, J. B., Kursawe, N., Solano, M. E., Patas, K., Wehrmann, S., Heckmann, N., Lühder, F., Reichardt, H. M., Arck, P., Gold, S. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617115114 · Cited by 126
“Proc Natl Acad Sci USA 107(20):9299–9304.”
Lin, Y. ‐., Shieh, C. ‐., & Wang, J. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01526.x · Cited by 139
“Thymus-derived naturally occurring regulatory T cells (nTreg) are CD4CD25 T cells, functionally distinguished by their capacity to limit CD4CD25 T-cell proliferation and Th1/Th2 cytokines production (6, 7).”
BackgroundYates, J. B., Rovis, F., Mitchell, P., Afzali, B., Tsang, J. Y., Garin, M. I., Lechler, R. I., Lombardi, G., & Garden, O. A. (2007) · International Immunology · doi:10.1093/intimm/dxm047 · Cited by 125
Crosstalk between T Lymphocytes and Dendritic Cells
Hivroz, C., Chemin, K., Tourret, M., & Bohineust, A. (2012) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v32.i2.30 · Cited by 112
Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity
Chen, M., Huang, L. F., & Wang, J. (2007) · Blood · doi:10.1182/blood-2006-11-056424 · Cited by 133
HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome
Lai, R., Meintjes, G., & Wilkinson, R. J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0532-2 · Cited by 119
“As mentioned above, Foxp3 CD4 T cells (considered as Treg) cells are critical in maintaining T cell homeostasis [85].”
BackgroundRouse, M., Singh, N. P., Nagarkatti, P. S., & Nagarkatti, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12205 · Cited by 111
Ricciardelli, I., Lindley, K. J., Londei, M., & Quaratino, S. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02839.x · Cited by 111
Lin, Y., Mahalingam, J., Chiang, J., Su, P., Chu, Y., Lai, H., Fang, J., Huang, C., Chiu, C., & Lin, C. (2013) · International Journal of Cancer · doi:10.1002/ijc.27784 · Cited by 112
“CD4þ Foxp3þ Regulatory T cells (Treg cells) are essential to maintain self-tolerance and immune hemostasis.(1,2) They play important roles in a variety of human diseases including autoimmune disease, chronic infection and cancers.”
BackgroundThe effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice
Qu, Y., Zhang, B., Zhao, L., Liu, G., Ma, H., Rao, E., Zeng, C., & Zhao, Y. X. (2007) · Transplant Immunology · doi:10.1016/j.trim.2007.01.002 · Cited by 111
“002 important role in immune tolerance to self antigens and allografts [4,5].”
BackgroundEnd-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells
Hendrikx, T. K., van Gurp, E. A. F. J., Mol, W. M., Schoordijk, W., Sewgobind, V. D. K. D., IJzermans, J. N. M., Weimar, W., & Baan, C. C. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp005 · Cited by 111
“The CD4+CD25bright+ T-cell, which specifically expresses the transcription factor FoxP3+, controls immune responses of effector T-cells to auto and foreign antigens [11–13].”
BackgroundT lymphocytes: a role in hypertension?
Schiffrin, E. L. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283360a2e · Cited by 124
Huber, S., Stahl, F. R., Schrader, J., Lüth, S., Presser, K., Carambia, A., Flavell, R. A., Werner, S., Blessing, M., Herkel, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803143 · Cited by 110
“T he maintenance of peripheral immune tolerance and prevention of chronic inflammation and autoimmune disease require CD4 CD25 Foxp3 regulatory T cells (Treg)(3) (1).”
BackgroundFactors affecting disease manifestation of toxocarosis in humans: Genetics and environment
Fan, C., Liao, C., & Cheng, Y.-C. (2012) · Veterinary Parasitology · doi:10.1016/j.vetpar.2012.12.030 · Cited by 123
“These cells have been characterized by constitutive expression of CD4+ and CD25+ (IL-2 receptor a chain) on the cell surface and by the presence of Forkhead box p3 (Foxp3) (Sakaguchi, 2005).”
BackgroundFOXP3 and NFAT: Partners in Tolerance
Rudensky, A. Y., Gavin, M. A., & Zheng, Y. (2006) · Cell · doi:10.1016/j.cell.2006.07.005 · Cited by 110
“In addition to TCR triggering, recent in vitro studies suggested a role for high dose of TGF-β in FOXP3 induction in peripheral T cells (Figure 2; reviewed in Sakaguchi, 2005).”
BackgroundResultInfluentialT Lymphocytes in Sjögren’s Syndrome: Contributors to and Regulators of Pathophysiology
Katsifis, G. E., Moutsopoulos, N. M., & Wahl, S. M. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-8011-8 · Cited by 117
The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation
Lin, J., Li, M., Wang, Z., He, S., Ma, X., & Li, D. (2009) · Journal of Lipid Research · doi:10.1194/jlr.d000497 · Cited by 110
Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells
Hiwarkar, P., Qasim, W., Ricciardelli, I., Gilmour, K. C., Quezada, S. A., Saudemont, A., Amrolia, P. J., & Veys, P. A. (2015) · Blood · doi:10.1182/blood-2015-06-654780 · Cited by 115
“The immunosuppressive role of FoxP3(1) regulatory T cells as a crucial tumor immune-evading mechanism is well established.(46-49) In a meta-analysis of TILs in cancer sections, although CD3(1) and CD8(1) TILs were associated with good prognosis and improved survival, the CD8(1)/FoxP3(1) ratio produced a more impressiv…”
BackgroundTebartz, C., Horst, S. A., Sparwasser, T. D., Huehn, J., Beineke, A., Peters, G., & Medina, E. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1400196 · Cited by 120
“Generally, Treg are characterized by the expression of CD4 and Foxp3, and they can exert a potent suppressive effect on other immune cells (37).”
BackgroundInfluentialThe autoimmune origin of atherosclerosis
Blasi, C. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.025 · Cited by 118
“This regulation is carried on principally by the T regulatory” cells (Treg) [148,149].”
BackgroundMechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells
Huang, C.-H., Yang, T.-T., & Lin, K. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01003-y · Cited by 125
Fernandez, M. A., Puttur, F. K., Wang, Y. M., Howden, W., Alexander, S. I., & Jones, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1556 · Cited by 109
“Definitive studies of Treg depletion and reconstitution including neonatal thymectomy (1, 4), scurfy mice (defective in Foxp3) (5, 6), and humans with foxp3 mutations and autoimmune disease (IPEX syndrome) (7) have demonstrated that Tregs dominantly suppress autoimmune disease from self-reactive T cells.”
BackgroundFunctional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo
Ben Ahmed, M., Zaraa, I., Rekik, R., Elbeldi‐Ferchiou, A., Kourda, N., Belhadj Hmida, N., Abdeladhim, M., Karoui, O., Ben Osman, A., Mokni, M., et al. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00920.x · Cited by 106
“Noticeably, natural CD4 CD25 T-regulatory cells (Tregs) constitute a key mechanism maintaining peripheral self-tolerance (Sakaguchi, 2005) through the control of auto-reactive lymphocyte activation and the prevention of deleterious effects of such activation.”
BackgroundInfluentialBonelli, M. M., von Dalwigk, K., Savitskaya, A., Smolen, J. S., & Scheinecker, C. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074690 · Cited by 119
“contrast to CD25 the expression of Foxp3 was shown to be T cell activation independent.(19)”
MethodZhou, P., L’italien, L., Hodges, D., & Schebye, X. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7365 · Cited by 107
“Treg cells not only engage in the maintenance of immunologic self-tolerance in the periphery but also play a predominant role in impeding immunosurveillance against autologous tumor cells (6, 7).”
BackgroundImproving Antitumor Immune Responses by Circumventing Immunoregulatory Cells and Mechanisms
Lizee, G. A., Radvanyi, L. G., Overwijk, W. W., & Hwu, P. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0944 · Cited by 112
“Treg (CD4CD25) Inhibition of CD4 and CD8 T cell proliferation through direct cell-to-cell interactions (11, 187)”
BackgroundExpansion of regulatory T cells via IL‐2/anti‐IL‐2 mAb complexes suppresses experimental myasthenia
Liu, R., Zhou, Q., Cava, A. L., Campagnolo, D. I., Kaer, L. V., & Shi, F. (2010) · European Journal of Immunology · doi:10.1002/eji.200939792 · Cited by 116
Culton, D. A., Qian, Y., Li, N., Rubenstein, D., Aoki, V., Filho, G. H., Rivitti, E. A., & Diaz, L. A. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.08.003 · Cited by 108
“Although the disease causing autoantibodies in pemphigus are produced by terminally differentiated B cells, autoreactive T cells play an important role by providing B cell help during activation directly and by TH2 cytokine secretion [88,91,93,94,143,144].”
BackgroundDysregulation of the immune system caused by silica and asbestos
Maeda, M., Nishimura, Y., Kumagai, N., Hayashi, H., Hatayama, T., Katoh, M., Miyahara, N., Yamamoto, S., Hirastuka, J., & Otsuki, T. (2010) · Journal of Immunotoxicology · doi:10.3109/1547691x.2010.512579 · Cited by 110
“…antigen-antibody-based events, including autoimmunity, allergy, tumor immunity, resistance to infection, graft-versus-host diseases, and control of pregnancy (Fehérvari and Sakaguchi, 2004; Hori and Sakaguchi, 2004; Sakaguchi, 2005; Dejaco et al., 2006; Sakaguchi et al., 2006; Oh et al., 2010).”
BackgroundIn vivo sites and cellular mechanisms of T reg cell–mediated suppression
Rudensky, A. Y., & Campbell, D. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060214 · Cited by 116
Boschetti, G., Nancey, S., Sardi, F., Roblin, X., Flourié, B., & Kaiserlian, D. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21308 · Cited by 121
“regulators of peripheral self-tolerance.(17) Tregs contribute to oral tolerance,(18,19) maintenance of gut homeostasis, and protection against intestinal inflammation.”
BackgroundThe T‐cell receptor repertoire of regulatory T cells
Pacholczyk, R., & Kern, J. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02992.x · Cited by 103
Modulators of arginine metabolism support cancer immunosurveillance
Capuano, G., Rigamonti, N., Grioni, M., Freschi, M., & Bellone, M. (2009) · BMC Immunology · doi:10.1186/1471-2172-10-1 · Cited by 113
“They selectively express Foxp3, a forkhead/winged helix transcription factor that controls master genes in Treg development/function [3].”
Oda, J. M. M., Hirata, B. K. B., Guembarovski, R. L., & Watanabe, M. A. E. (2013) · Journal of Genetics · doi:10.1007/s12041-013-0213-7 · Cited by 123
“α - chain (CD25) and their phenotype is now generally accepted as CD4+CD25hiCTLA4+GITR+FOXP3+ CD45RO+CD45RA−CD69−Ki-67− (Sakaguchi 2005; Betts et al. 2006).”
BackgroundThe imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients
Ma, J., Yu, J., Tao, X., Cai, L., Wang, J., & Zheng, S. G. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1510-7 · Cited by 118
“Th1 cells produce mainly interferon-gamma (IFN-γ) and promote cellmediated immunity, whereas Th2 cells secrete IL-4, IL-5, IL-6, and IL-10, being associated with humoral immune responses, and inducing antibody production [4, 5]. Recent evidence has highlighted the role of regulatory T (Treg) cells in the induction and…”
BackgroundRegulatory T Cells Modulate Postischemic Neovascularization
Zouggari, Y., Ait‐Oufella, H., Waeckel, L., Vilar, J., Loinard, C., Cochain, C., Récalde, A., Duriez, M., Levy, B. I., Lutgens, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.875583 · Cited by 109
T Regulatory Cell Levels Decrease in People Infected With Schistosoma mansoni on Effective Treatment
Watanabe, K., Mwinzi, P. N. M., Black, C. L., Muok, E. M. O., Karanja, D. M. S., Secor, W. E., & Colley, D. G. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.676 · Cited by 106
Furcron, A.-E., Romero, R. J., Plazyo, O., Unkel, R., Xu, Y., Hassan, S. S., Chaemsaithong, P., Mahajan, A., & Gomez‐Lopez, N. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.010 · Cited by 113
Boasso, A., Vaccari, M., Hryniewicz, A., Fuchs, D., Nacsa, J., Cecchinato, V., Andersson, J., Franchini, G., Shearer, G. M., & Chougnet, C. A. (2007) · Journal of Virology · doi:10.1128/jvi.00760-07 · Cited by 106
“FoxP3 and CTLA-4 not only are expressed by Treg but can also be transiently expressed by recently activated T cells ( 37 ).”
BackgroundToll‐like receptor signalling on Tregs: to suppress or not to suppress?
van Maren, W. W. C., Jacobs, J. F. M., de Vries, I. J. M., Nierkens, S., & Adema, G. J. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02871.x · Cited by 119
Signatures of human regulatory T cells: an encounter with old friends and new players
Pfoertner, S., Jeron, A., Probst-Kepper, M., Guzman, C. A., Hansen, W., Westendorf, A. M., Toepfer, T., Schrader, A. J., Franzke, A., Buer, J., et al. (2006) · Genome Biology · doi:10.1186/gb-2006-7-7-r54 · Cited by 107
“TReg cells actively suppress activation and expansion of self-reactive escapees as part of a process termed peripheral tolerance [1].”
BackgroundComes, A., Rosso, O., Orengo, A. M., Carlo, E. D., Sorrentino, C., Meazza, R., Piazza, T., Valzasina, B., Nanni, P., Colombo, M. P., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1750 · Cited by 107
“displayed several features of naturally arising Tregs (46): they”
BackgroundThymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?
Povoleri, G. A. M., Scottà, C., Nova‐Lamperti, E., John, S., Lombardi, G., & Afzali, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00169 · Cited by 124
“, 1999) or anti-pathogen responses (Sakaguchi, 2005).”
BackgroundKikuchi, H., Yuan, B., Hu, X., & Okazaki, M. (2019) · PubMed · Cited by 109
Impaired in vitro regulatory T cell function associated with Wiskott–Aldrich syndrome
Adriani, M., Aoki, J., Horai, R., Thornton, A. M., Konno, A., Kirby, M., Anderson, S. M., Siegel, R. M., Candotti, F., & Schwartzberg, P. L. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.02.001 · Cited by 105
“It has recently been recognized that CD4+CD25+ Treg cells play an important role in the negative regulation of immune responses and the prevention of autoimmunity (11-13).”
BackgroundRegulatory T cells: immune suppression and beyond
Wan, Y. Y. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.20 · Cited by 114
CTLA‐4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice
Kolar, P., Knieke, K., Hegel, J. K., Quandt, D., Burmester, G. R., Hoff, H., & Brunner-Weinzierl, M. C. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24181 · Cited by 114
Álvarez-Quiroga, C., Abud‐Mendoza, C., Doníz-Padilla, L., Juárez-Reyes, A., Monsiváis-Urenda, A. E., Baranda, L., & González‐Amaro, R. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9527-5 · Cited by 107
“However, many key aspects of Treg cell biology remain unsolved, mainly those related with the cellular and molecular pathways involved in their development and mechanism of action [ 5 ].”
BackgroundInfluentialOverview of Traumatic Brain Injury: An Immunological Context
Nizamutdinov, D., & Shapiro, L. (2017) · Brain Sciences · doi:10.3390/brainsci7010011 · Cited by 100
“They derive from naive CD4 cells and are known for their immunosuppressive action, which downregulate the induction and proliferation of effector T cells [159,160].”
BackgroundMesenchymal Stem Cells for Perianal Crohn’s Disease
Carvello, M., Lightner, A. L., Yamamoto, T., Kotze, P. G., & Spinelli, A. (2019) · Cells · doi:10.3390/cells8070764 · Cited by 111
Tryptophan catabolism generates autoimmune-preventive regulatory T cells
Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., et al. (2006) · Transplant Immunology · doi:10.1016/j.trim.2006.09.017 · Cited by 104
Khan, K. D., Emmanouilides, C., Benson, D. M., Hurst, D., Garcia, P., Michelson, G., Milan, S., Ferketich, A. K., Piro, L., Leonard, J. P., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1571 · Cited by 99
Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?
Visperas, A., & Vignali, D. A. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601118 · Cited by 115
Yu, Y., Zhu, S., Li, P., Min, L., & Zhang, S. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0982-2 · Cited by 109
Aarts‐Riemens, T., Emmelot, M. E., Verdonck, L. F., & Mutis, T. (2008) · European Journal of Immunology · doi:10.1002/eji.200737590 · Cited by 101
A Potential Side Effect of Cyclosporin A: Inhibition of CD4+CD25+ Regulatory T Cells in Mice
Wang, H., Zhao, L., Sun, Z., Sun, L., Zhang, B., & Zhao, Y. (2006) · Transplantation · doi:10.1097/01.tp.0000246312.89689.17 · Cited by 101
Genre, J., Errante, P. R., Kokron, C. M., Toledo-Barros, M. A. M., Câmara, N. O. S., & Rizzo, L. V. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.03.519 · Cited by 102
Mutis, T., van Rijn, R. V., Simonetti, E., Aarts-Riemens, T., Emmelot, M., van Bloois, L., Martens, A., Verdonck, L., & Ebeling, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0035 · Cited by 100
Chapter 3 Thymic Microenvironments for T-Cell Repertoire Formation
Nitta, T., Murata, S., Ueno, T., Tanaka, K., & Takahama, Y. (2008) · Advances in immunology · doi:10.1016/s0065-2776(08)00603-2 · Cited by 120
Kong, Q., Sun, B., Bai, S., Zhai, D., Wang, G., Liu, Y., Zhang, S., Li, R., Zhao, W., Sun, Y., et al. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.005 · Cited by 101
“They are especially important in maintaining self-tolerance and inhibiting the developmentof autoimmunity (Wanget al., 2007;Sakaguchi, 2005).”
BackgroundDietze, K. K., Zelinskyy, G., Sutter, K., Schimmer, S., Francois, S., Myers, L. M., Sparwasser, T. D., Hasenkrug, K. J., & Dittmer, U. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015148108 · Cited by 123
“Because Tregs are important in controlling autoimmune diseases (33), another obvious concern with Treg ablation therapy is the possibility of inducing immunopathology.”
BackgroundBrunet, M., Shipkova, M., van Gelder, T., Wieland, E., Sommerer, C., Budde, K., Haufroid, V., Christians, U., López‐Hoyos, M., Barten, M. J., et al. (2016) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000287 · Cited by 106
“In humans, they are characterized by high expression of CD25 (the a-chain of the IL-2 receptor), in contrast to the effector CD4+ T cells, which express lower, transient levels of CD25, and expression of the transcription factor Foxp3.(49) It has recently been demonstrated that the expression of Foxp3 is not as specif…”
BackgroundZelinskyy, G., Kraft, A. R. M., Schimmer, S., Arndt, T., & Dittmer, U. (2006) · European Journal of Immunology · doi:10.1002/eji.200636059 · Cited by 102
Lee, J. C., Hayman, E., Pegram, H. J., Santos, E., Heller, G., Sadelain, M., & Brentjens, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0552 · Cited by 101
“nTregs have been found to facilitate suppression of autoimmune T-cell responses and maintenance of peripheral tolerance (12–14), represent approximately 5% to 10% of peripheral CD4þ T cells in both mice and humans (13, 15), and expresshigh levels of cytotoxicT lymphocyte associated antigen 4 (CTLA-4), glucocorticoid-i…”
BackgroundRegulatory T cells and tumour immunity – observations in mice and men
Gallimore, A., & Godkin, A. J. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02748.x · Cited by 116
Li, N., Bian, H., Zhang, J., Li, X., Ji, X., & Zhang, Y. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.08.013 · Cited by 109
The Role of Different Subsets of Regulatory T Cells in Immunopathogenesis of Rheumatoid Arthritis
Golara, M., Jadidi‐Niaragh, F., Sadria, R., Azizi, G., & Mirshafiey, A. (2012) · Arthritis · doi:10.1155/2012/805875 · Cited by 100
“Since then, various studies tried to find the different features and functions of these cells in immune system and the immunopathophysiology of different diseases such as cancer and autoimmune diseases.”
BackgroundCD226: An Emerging Role in Immunologic Diseases
Huang, Z., Qi, G., Miller, J. S., & Zheng, S. G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00564 · Cited by 118
Makita, S., Kanai∥, T., Nemoto, Y., Totsuka, T., Okamoto, R., Tsuchiya, K., Yamamoto, M., Kiyono, H., & Watanabe, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4937 · Cited by 111
“CD4 CD25 regulatory T (TREG) 3 cells fulfill a central role in the maintenance of immunological homeostasis and self-tolerance (4, 5).”
BackgroundTiittanen, M., Westerholm‐Ormio, M., Verkasalo, M., Savilahti, E., & Vaarala, O. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03662.x · Cited by 100
Vandenbark, A. A., Huan, J., Agotsch, M., Tocha, D. L., Goelz, S. E., Offner, H., Lanker, S., & BOURDETTE, D. N. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.08.007 · Cited by 100
“The role of natural immunoregulatory CD4+CD25+Foxp3+ Treg cells in the prevention of autoimmunity is now well documented (Sakaguchi, 2005; Shevach, 2000; Vandenbark and Offner, 2008), as are observations that Treg cells in RRMS patients have a significantly reduced suppressive ability (Haas et al.”
BackgroundGaining insight into PTPN22 and autoimmunity
Gregersen, P. K. (2005) · Nature Genetics · doi:10.1038/ng1205-1300 · Cited by 100
Mourmouras, V., Biagioli, M., Miracco, C., Luzi, P., Tosi, P., Cosci, E., Monciatti, I., Mannucci, S., & Rubegni, P. (2007) · Oncology Reports · doi:10.3892/or.18.5.1115 · Cited by 93
Regulatory T-cell Trafficking: From Thymic Development to Tumor-Induced Immune Suppression
Mailloux, A. W., & Young, M. R. (2010) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v30.i5.30 · Cited by 103
Metadata
- Authors
- Sakaguchi, S.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Sakaguchi, Shimon
- ORCID
- Sakaguchi, Shimon
- Venue
- Nature Immunology
- Published
- 2005-03-22
- Volume
- 6
- Issue
- 4
- Pages
- 345-352
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2004708987
- Cited by
- 2,669
- References
- 109
- Citations by year
- 2026: 12 · 2025: 33 · 2024: 39 · 2023: 54 · 2022: 59 · 2021: 68 · 2020: 68 · 2019: 84 · 2018: 83 · 2017: 92 · 2016: 98 · 2015: 113 · 2014: 127 · 2013: 148 · 2012: 169
- FWCI
- 22.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- Foxp3, regulatory T cells, CD4+CD25+ T cells, immune tolerance, self-tolerance, autoimmune disease, antitumor immunity, transplantation tolerance, antigen-specific T cell expansion, immunomodulation
- MeSH terms
- Animals, Antigens, Differentiation, Autoimmune Diseases, DNA-Binding Proteins, Humans, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Thymus Gland, Transplantation Immunology, Receptors, Interleukin-2, Antigens, CD, CD4 Antigens, Self Tolerance, Forkhead Transcription Factors, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.